JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Main Street Capital
MAIN
$5.54B
| $6.48M | ﹤0.01% |
150,394
+48,634
| +48% | +$2.08M |
|
2377
Watts Water Technologies
WTS
$12.8B
| $6.48M | ﹤0.01% |
64,930
+8,956
| +16% | +$850K |
|
|
CVGW
2378
DELISTED
Calavo Growers
CVGW
| $6.47M | ﹤0.01% |
71,396
+36,464
| +104% | +$3.26M |
|
2379
CALL
PG&E
PCG
$38.5B
| $6.47M | ﹤0.01% |
595,000
+530,000
| +815% | +$4.54M |
|
2380
Vanguard International High Dividend Yield ETF
VYMI
$21.3B
| $6.47M | ﹤0.01% |
101,204
+26,011
| +35% | +$1.61M |
|
2381
Fox Class B
FOX
$24.4B
| $6.46M | ﹤0.01% |
177,622
+62,619
| +54% | +$2.1M |
|
|
LOMA
2382
CALL
Loma Negra
LOMA
$1.11B
| $6.45M | ﹤0.01% |
825,000
-187,500
| -19% | -$1.19M |
|
|
PPL
2383
PUT
PPL Corp
PPL
$26.8B
| $6.45M | ﹤0.01% |
179,800
| – | – |
|
2384
ALPS Sector Dividend Dogs ETF
SDOG
$1.45B
| $6.45M | ﹤0.01% |
137,758
+8,424
| +7% | +$380K |
|
2385
PUT
JD.com
JD
$39.6B
| $6.45M | ﹤0.01% |
183,000
-600
| -0.3% | -$19.4K |
|
2386
PUT
Sempra
SRE
$56.5B
| $6.44M | ﹤0.01% |
85,000
| – | – |
|
2387
CALL
StoneCo
STNE
$2.49B
| $6.43M | ﹤0.01% |
161,300
+143,800
| +822% | +$5.26M |
|
2388
PUT
EQT Corp
EQT
$33.8B
| $6.43M | ﹤0.01% |
+590,000
| New | +$5.77M |
|
2389
PUT
Stryker
SYK
$131B
| $6.4M | ﹤0.01% |
30,500
| – | – |
|
2390
Fate Therapeutics
FATE
$294M
| $6.39M | ﹤0.01% |
326,820
+47,069
| +17% | +$747K |
|
|
TELL
2391
DELISTED
Tellurian Inc.
TELL
| $6.36M | ﹤0.01% |
873,830
+24,623
| +3% | +$187K |
|
2392
NBT Bancorp
NBTB
$2.79B
| $6.35M | ﹤0.01% |
156,649
+12,986
| +9% | +$509K |
|
|
GOL
2393
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $6.35M | ﹤0.01% |
351,619
-401,613
| -53% | -$6.83M |
|
|
FLG
2394
Flagstar Bank National Association
FLG
$5.92B
| $6.35M | ﹤0.01% |
176,014
-90,853
| -34% | -$3.35M |
|
2395
VSE Corp
VSEC
$6.48B
| $6.34M | ﹤0.01% |
166,792
-56,236
| -25% | -$2.09M |
|
|
ABMD
2396
CALL
DELISTED
Abiomed Inc
ABMD
| $6.33M | ﹤0.01% |
+37,100
| New | +$6.88M |
|
|
APLS
2397
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $6.32M | ﹤0.01% |
+206,500
| New | +$5.72M |
|
2398
Cedar Fair
FUN
$1.71B
| $6.32M | ﹤0.01% |
113,941
-314,317
| -73% | -$17.7M |
|
2399
CALL
American Express
AXP
$232B
| $6.3M | ﹤0.01% |
50,600
-63,300
| -56% | -$7.57M |
|
2400
First Citizens BancShares
FCNCA
$25.6B
| $6.3M | ﹤0.01% |
11,834
-22,104
| -65% | -$11.2M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.